Alexion Pharmaceuticals Stock News

A stock can be cheap but not be a bargain. At least two of these stocks appear to be both.

The coronavirus crash has pushed forward price-to-earnings ratios for these healthcare companies down to between 3 and 7.

Significant pullbacks in the market have always been an opportune time to put your money to work.

Buy, hold, and profit big-time from these three solid business models.

If you have disposable income to invest, now is the time to put it to work on some big-name bargains.

Here are some recommendations as the stock market decline continues.

Alexion (ALXN) reported earnings 30 days ago. What's next for the stock?

These are the health care stocks with the best value, fastest growth, and most momentum for March.

Alexion Pharmaceuticals: Pipeline Diversification Outweighs The Patent Uncertainty

Initiating A Piotroski Portfolio With Nine Top-Quality Stocks

Alexion Pharmaceuticals: Revising My Valuation

Alexion Pharmaceuticals Is On Sale

Alexion Pharmaceuticals Inc (ALXN) CEO Ludwig Hantson on Q4 2019 Results - Earnings Call Transcript

Alexion (ALXN) beats on earnings and revenues in the fourth quarter of 2019.

Shares of Alexion Pharmaceuticals (NASDAQ: ALXN) fell about 2% after the company reported Q4 results.